Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of GW823093 in Japanese T2DM Patients
NCT00372957Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of denagliptin in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Mar 2006; status: completed.
02
Drugs
denagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00372957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372957.